Normal serum alanine aminotransferase levels for screening metabolic dysfunction- associated fatty liver disease

被引:5
|
作者
Yang, Junli [1 ]
Hou, Yeting [2 ]
Zhang, Qiang [1 ]
Wang, Yanfang [1 ]
机构
[1] Inner Mongolia Med Univ, Affiliated Hosp, Phys Examinat Ctr, Hohhot 010050, Peoples R China
[2] Inner Mongolia Med Univ, Affiliated Hosp, Dept Gastroenterol, Hohhot 010050, Peoples R China
关键词
D O I
10.1016/j.jfma.2023.05.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1092 / 1093
页数:2
相关论文
共 50 条
  • [21] Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight
    Eslam, Mohammed
    El-Serag, Hashem B.
    Francque, Sven
    Sarin, Shiv K.
    Wei, Lai
    Bugianesi, Elisabetta
    George, Jacob
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2022, 19 (10) : 638 - 651
  • [22] Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight
    Mohammed Eslam
    Hashem B. El-Serag
    Sven Francque
    Shiv K. Sarin
    Lai Wei
    Elisabetta Bugianesi
    Jacob George
    Nature Reviews Gastroenterology & Hepatology, 2022, 19 : 638 - 651
  • [23] Histological Abnormalities in Children with Nonalcoholic Fatty Liver Disease and Normal or Mildly Elevated Alanine Aminotransferase Levels
    Molleston, Jean P.
    Schwimmer, Jeffrey B.
    Yates, Katherine P.
    Murray, Karen F.
    Cummings, Oscar W.
    Lavine, Joel E.
    Brunt, Elizabeth M.
    Scheimann, Ann O.
    Unalp-Arida, Aynur
    JOURNAL OF PEDIATRICS, 2014, 164 (04): : 707 - U54
  • [24] Obesity and alanine aminotransferase are associated with metabolic syndrome in patients with ultrasonographic fatty liver
    Soo, Kim Sung
    Sun, Kim Chul
    Min, Kim Kyoung
    Sung, Kim Jong
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 : S159 - S159
  • [25] Personalisierte Therapie der metabolisch assoziierten FettlebererkrankungPersonalized treatment of metabolic (dysfunction-)associated fatty liver disease
    Jan Clusmann
    Kai Markus Schneider
    Paul-Henry Koop
    Mathias Plauth
    Carolin Victoria Schneider
    Die Gastroenterologie, 2023, 18 : 300 - 307
  • [26] The spectrum of nonalcoholic fatty liver disease utilizing the updated limits of normal serum aminotransferase levels
    Kunde, S
    Abrams, G
    Clements, RH
    GASTROENTEROLOGY, 2005, 128 (04) : A768 - A768
  • [27] JIGUCAO CAPSULE ALLEVIATES METABOLIC DYSFUNCTION- ASSOCIATED FATTY LIVER DISEASE BY REGULATING THE GUT MICROBIOTA AND LIPID METABOLISM
    Qi, Wenying
    Chen, Yue
    Cao, Xu
    Chen, Hening
    Zhang, Ningyi
    Liu, Ruijia
    Wang, Wei
    Ye, Yong'An
    Zao, Xiaobin
    HEPATOLOGY, 2024, 80 : S81 - S82
  • [28] Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase
    Lopez-Suarez, Alejandro
    Rodriguez Guerrero, Jose Maria
    Elvira-Gonzalez, Javier
    Beltran-Robles, Manuel
    Canas-Hormigo, Francisco
    Bascunana-Quirell, Antonio
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (11) : 1011 - 1017
  • [29] Acomplementto epigenetics in metabolic dysfunction- associated steatotic liver disease: Editorial on "DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction- associated steatotic liver disease"
    Distefano, Johanna K.
    Gerhard, Glenn S.
    CLINICAL AND MOLECULAR HEPATOLOGY, 2025, 31 (01)
  • [30] Screening for metabolic dysfunction-associated fatty liver disease: Time to discard the emperor's clothes of normal liver enzymes?
    Huang, Chen-Xiao
    Zhou, Xiao-Dong
    Pan, Calvin Q.
    Zheng, Ming-Hua
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (22) : 2839 - 2842